Literature DB >> 21334745

Numbers and proportions of leukemias in young people and adults induced by radiation of natural origin.

Gerald Kendall1, Mark P Little, Richard Wakeford.   

Abstract

Natural sources contribute a large fraction of the radiation exposure of the general public. Under the linear no-threshold hypothesis risk decreases in proportion to decreasing dose without a threshold. We use recent estimates of doses to the red bone marrow to calculate the number and proportion of cases of leukemia in England induced by natural radiation. We calculate that about 5% of cases of leukemia, excluding chronic lymphocytic leukemia, up to the age of 80 years are induced by this background radiation. In young people up to the age of 25 years the attributable fraction is about 15%, substantially lower than a previous estimate.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21334745      PMCID: PMC3998761          DOI: 10.1016/j.leukres.2011.01.023

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  17 in total

1.  Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan.

Authors:  J H FOLLEY; W BORGES; T YAMAWAKI
Journal:  Am J Med       Date:  1952-09       Impact factor: 4.965

2.  Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies.

Authors:  S Darby; D Hill; A Auvinen; J M Barros-Dios; H Baysson; F Bochicchio; H Deo; R Falk; F Forastiere; M Hakama; I Heid; L Kreienbrock; M Kreuzer; F Lagarde; I Mäkeläinen; C Muirhead; W Oberaigner; G Pershagen; A Ruano-Ravina; E Ruosteenoja; A Schaffrath Rosario; M Tirmarche; L Tomásek; E Whitley; H-E Wichmann; R Doll
Journal:  BMJ       Date:  2004-12-21

3.  Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies.

Authors:  Daniel Krewski; Jay H Lubin; Jan M Zielinski; Michael Alavanja; Vanessa S Catalan; R William Field; Judith B Klotz; Ernest G Létourneau; Charles F Lynch; Joseph I Lyon; Dale P Sandler; Janet B Schoenberg; Daniel J Steck; Jan A Stolwijk; Clarice Weinberg; Homer B Wilcox
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

4.  Residential radon and lung cancer--detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe.

Authors:  Sarah Darby; David Hill; Harz Deo; Anssi Auvinen; Juan Miguel Barros-Dios; Hélène Baysson; Francesco Bochicchio; Rolf Falk; Sara Farchi; Adolfo Figueiras; Matti Hakama; Iris Heid; Nezahat Hunter; Lothar Kreienbrock; Michaela Kreuzer; Frédéric Lagarde; Ilona Mäkeläinen; Colin Muirhead; Wilhelm Oberaigner; Göran Pershagen; Eeva Ruosteenoja; Angelika Schaffrath Rosario; Margot Tirmarche; Ladislav Tomásek; Elise Whitley; Heinz-Erich Wichmann; Richard Doll
Journal:  Scand J Work Environ Health       Date:  2006       Impact factor: 5.024

5.  Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?

Authors:  Mark P Little; Per Hall; Monty W Charles
Journal:  Radiat Environ Biophys       Date:  2007-07-17       Impact factor: 1.925

Review 6.  Radiation doses and risks from internal emitters.

Authors:  John Harrison; Philip Day
Journal:  J Radiol Prot       Date:  2008-05-22       Impact factor: 1.394

7.  Risk of lung cancer and residential radon in China: pooled results of two studies.

Authors:  Jay H Lubin; Zuo Yuan Wang; John D Boice; Zhao Yi Xu; William J Blot; Long De Wang; Ruth A Kleinerman
Journal:  Int J Cancer       Date:  2004-03       Impact factor: 7.396

8.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

Authors:  D L Preston; S Kusumi; M Tomonaga; S Izumi; E Ron; A Kuramoto; N Kamada; H Dohy; T Matsuo; T ] Matsui T [corrected to Matsuo
Journal:  Radiat Res       Date:  1994-02       Impact factor: 2.841

9.  Changes in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979-2003.

Authors:  Robert D Alston; Marco Geraci; Tim O B Eden; Anthony Moran; Steve Rowan; Jillian M Birch
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

Review 10.  Ionizing radiation, part 2: some internally deposited radionuclides. Views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 14-21 June 2000.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2001
View more
  6 in total

1.  Background gamma radiation and childhood cancer in Germany: an ecological study.

Authors:  Claudia Spix; Bernd Grosche; Martin Bleher; Peter Kaatsch; Peter Scholz-Kreisel; Maria Blettner
Journal:  Radiat Environ Biophys       Date:  2017-03-23       Impact factor: 1.925

Review 2.  Acute lymphoblastic leukaemia.

Authors:  Hiroto Inaba; Mel Greaves; Charles G Mullighan
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321

Review 3.  Occurrence of ²¹⁰Po and biological effects of low-level exposure: the need for research.

Authors:  Ralph L Seiler; Joseph L Wiemels
Journal:  Environ Health Perspect       Date:  2012-04-26       Impact factor: 9.031

4.  Leukaemia incidence in the Techa River Cohort: 1953-2007.

Authors:  L Y Krestinina; F G Davis; S Schonfeld; D L Preston; M Degteva; S Epifanova; A V Akleyev
Journal:  Br J Cancer       Date:  2013-10-15       Impact factor: 7.640

Review 5.  Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.

Authors:  Monika Lejman; Aleksandra Chałupnik; Zuzanna Chilimoniuk; Maciej Dobosz
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

6.  Alpha-Particle-Induced Complex Chromosome Exchanges Transmitted through Extra-Thymic Lymphopoiesis In Vitro Show Evidence of Emerging Genomic Instability.

Authors:  Natalia Sumption; Dudley T Goodhead; Rhona M Anderson
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.